44 <strong>Biomedical</strong> <strong>Engineering</strong> <strong>–</strong> <strong>From</strong> <strong>Theory</strong> <strong>to</strong> <strong>Applications</strong> Ramjee, G., Kamali, A. & McCormack, S. (2010). The last decade of microbicide clinical trials in Africa: <strong>From</strong> hypothesis <strong>to</strong> facts. AIDS 24, Suppl 4: S40-S49. Ramjee, G., Kapiga, S., Weiss, S., Peterson, L., Leburg, C., Kelly, C., Mâsse, B. & HPTN Study Team (2008). The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials - Experience from the HPTN 055 study. Journal of Acquired Immune Deficiency Syndromes 47, 1: 93-100. Ramjee, G., van der Straten, A., Chipa<strong>to</strong>, T., de Bruyn, G., Blanchard, K., Shiboski, S., Cheng, H., Montgomery, E., Padian, N. & for the, M.t. (2008). The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: Results of a randomized controlled trial. PLoS One 3, 10: e3488. Rebbapragada, A. & Kaul, R. (2007). More than their sum in your parts: The mechanisms that underpin the mutually advantageous relationship between HIV and sexually transmitted infections. Drug Discovery Today: Disease Mechanisms 4, 4: 237-246. Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., Benenson, M., Gurunathan, S., Tartaglia, J., McNeil, J.G., Francis, D.P., Stablein, D., Birx, D.L., Chunsuttiwat, S., Khamboonruang, C., Thongcharoen, P., Robb, M.L., Michael, N.L., Kunasol, P., Kim, J.H. & the MOPH-TAVEG Investiga<strong>to</strong>rs (2009). Vaccination with ALVAC and AIDSVAX <strong>to</strong> prevent HIV-1 infection in Thailand. New England Journal of Medicine 361, 23: 2209-2220. Richens, R., Imrie, J. & Copas, A. (2000). Condoms and seat belts: The parallels and the lessons. The Lancet 355, 9201: 400-403. Richman, D.D., Wrin, T., Little, S.J. & Petropoulos, C.J. (2003). Rapid evolution of the neutralizing antibody response <strong>to</strong> HIV type 1 infection. Proceedings of the National Academy of Sciences of the United States of America 100, 7: 4144-4149. Rojanapithayakorn, W. & Hanenberg, R. (1996). The 100% condom program in Thailand. AIDS 10, 1: 1-8. Ruiz, P., Strain, E.C. & Langrod, J. (2007). The Substance Abuse Handbook Lippincott Williams & Wilkins, Philadelphia. Shapshak, P., McCoy, C.B., Shah, S.M., Page, J.B., Rivers, J.E., Weatherby, N.L., Chitwood, D.D. & Mash, D.C. (1994). Preliminary labora<strong>to</strong>ry studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. Journal of Acquired Immune Deficiency Syndromes 7, 7: 754-759. Skoler-Karpoff, S., Ramjee, G., Ahmed, K., Altini, L., Plagianos, M., Friedland, B., Govender, S., Dekock, A., Cassim, N. & Palanee, T. (2008). Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, doubleblind, placebo-controlled trial. The Lancet 372, 9654: 1977-1987. Stein, Z.A. (1990). HIV prevention: The need for methods women can use. American Journal of Public Health 80, 4: 460-462. S<strong>to</strong>neburner, R. & Low-Beer, D. (2004). Population-level HIV declines and behavioral risk avoidance in Uganda. Science 304, 5671: 714-718. Temple<strong>to</strong>n, D.J., Jin, F., Mao, L., Prestage, G.P., Donovan, B., Imrie, J., Kippax, S., Kaldor, J.M. & Grulich, A.E. (2009). Circumcision and risk of HIV infection in Australian homosexual men. AIDS 23, 17: 2347-2351 Tobian, A.A.R., Serwadda, D., Quinn, T.C., Kigozi, G., Gravitt, P.E., Laeyendecker, O., Charvat, B., Ssempijja, V., Riedesel, M. & Oliver, A.E. (2009). Male circumcision for
<strong>Biomedical</strong> HIV Prevention the prevention of HSV-2 and HPV infections and syphilis. New England Journal of Medicine 360, 13: 1298-1309. Tolley, E.E., Harrison, P.F., Goetghebeur, E., Morrow, K., Pool, R., Taylor, D., Tillman, S.N. & van der Straten, A. (2009). Adherence and its measurement in phase 2/3 microbicide trials. AIDS and Behavior 14, 5: 1124-1136. Toombs, J.D. & Kral, L.A. (2005). Methadone treatment for pain states. American Family Physician 71, 7: 1353-1358. UNAIDS (2010). Report on the global AIDS epidemic 2010 Joint United Nations Programme on HIV/AIDS, Geneva. van Damme, L., Ramjee, G., Alary, M., Vuylsteke, B., Chandeying, V., Rees, H., Sirivongrangson, P., Tshibaka, L., Ettiegnetraore, V. & Uaheowitchai, C. (2002). Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. The Lancet 360, 9338: 971-977. Van Den Berg, C., Smit, C., Van Brussel, G., Coutinho, R. & Prins, M. (2007). Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction 102, 9: 1454-1462. van Sighem, A., Gras, L., Reiss, P., Brinkman, K., de Wolf, F. & on behalf of the ATHENA national observational cohort study (2010). Life expectancy of recently diagnosed asymp<strong>to</strong>matic HIV-infected patients approaches that of uninfected individuals. AIDS 24, 10: 1527-1535 Vermund, S.H., Allen, K.L. & Karim, Q.A. (2009). HIV-prevention science at a crossroads: Advances in reducing sexual risk. Current Opinion in HIV and AIDS 4, 4: 266-273. Vijayakumar, G., Mabude, Z., Smit, J., Beksinska, M. & Lurie, M. (2006). A review of femalecondom effectiveness: Patterns of use and impact on protected sex acts and STI incidence. International Journal of STD & AIDS 17, 10: 652-659. Vlahov, D., Robertson, Angela M. & Strathdee, Steffanie A. (2010). Prevention of HIV infection among injection drug users in resource-limited settings. Clinical Infectious Diseases 50, S3: S114-S121. Walsh, S.L. & Eissenberg, T. (2003). The clinical pharmacology of buprenorphine: Extrapolating from the labora<strong>to</strong>ry <strong>to</strong> the clinic. Drug and Alcohol Dependence 70, 2, Supplement 1: S13-S27. Warren, M. & Philpott, A. (2003). Expanding safer sex options: Introducing the female condom in<strong>to</strong> national programmes. Reproductive Health Matters 11, 21: 130-139. Wasserheit, J.N. (1992). Epidemiological synergy: Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sexually Transmitted Diseases 19, 2: 61-77. Watson-Jones, D., Weiss, H.A., Rusizoka, M., Changalucha, J., Baisley, K., Mugeye, K., Tan<strong>to</strong>n, C., Ross, D., Everett, D., Clay<strong>to</strong>n, T., Balira, R., Knight, L., Hamble<strong>to</strong>n, I., Le Goff, J., Belec, L. & Hayes, R. (2008). Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. New England Journal of Medicine 358, 15: 1560-1571. Wawer, M., Makumbi, F., Kigozi, G., Serwadda, D., Watya, S., Nalugoda, F., Buwembo, D., Ssempijja, V., Kiwanuka, N. & Moul<strong>to</strong>n, L. (2009). Circumcision in HIV-infected men and its effect on HIV transmission <strong>to</strong> female partners in Rakai, Uganda: A randomised controlled trial. The Lancet 374, 9685: 229-237. 45
- Page 1 and 2:
BIOMEDICAL ENGINEERING - FROM THEOR
- Page 3:
free online editions of InTech Book
- Page 6: VI Contents Chapter 9 Targeted Magn
- Page 10: X Preface stand-alone and readers c
- Page 14 and 15: 2 Biomedical Engineering - From The
- Page 16 and 17: 4 Fig. 2. Process for retrieval inf
- Page 18 and 19: 6 Biomedical search engine Scientif
- Page 20 and 21: 8 Biomedical Engineering - From The
- Page 22 and 23: 10 Biomedical Engineering - From Th
- Page 24 and 25: 12 Bireme http://regional.bv salud.
- Page 26 and 27: 14 Semantic Networks analysis Biome
- Page 28 and 29: 16 Biomedical Engineering - From Th
- Page 30 and 31: 18 Biomedical Engineering - From Th
- Page 32 and 33: 20 Biomedical Engineering - From Th
- Page 34 and 35: 22 Biomedical Engineering - From Th
- Page 36 and 37: 24 Biomedical Engineering - From Th
- Page 38 and 39: 26 Biomedical Engineering - From Th
- Page 40 and 41: 28 Biomedical Engineering - From Th
- Page 42 and 43: 30 Biomedical Engineering - From Th
- Page 44 and 45: 32 Biomedical Engineering - From Th
- Page 46 and 47: 34 Biomedical Engineering - From Th
- Page 48 and 49: 36 Biomedical Engineering - From Th
- Page 50 and 51: 38 Biomedical Engineering - From Th
- Page 52 and 53: 40 Biomedical Engineering - From Th
- Page 54 and 55: 42 Biomedical Engineering - From Th
- Page 58 and 59: 46 Biomedical Engineering - From Th
- Page 60 and 61: 48 Biomedical Engineering - From Th
- Page 62 and 63: 50 Biomedical Engineering - From Th
- Page 64 and 65: 52 Biomedical Engineering - From Th
- Page 66 and 67: 54 Biomedical Engineering - From Th
- Page 68 and 69: 56 Biomedical Engineering - From Th
- Page 70 and 71: 58 Biomedical Engineering - From Th
- Page 72 and 73: 60 Biomedical Engineering - From Th
- Page 74 and 75: 62 Biomedical Engineering - From Th
- Page 76 and 77: 64 Biomedical Engineering - From Th
- Page 78 and 79: 66 Biomedical Engineering - From Th
- Page 80 and 81: 68 Biomedical Engineering - From Th
- Page 82 and 83: 70 Biomedical Engineering - From Th
- Page 84 and 85: 72 Biomedical Engineering - From Th
- Page 86 and 87: 74 Biomedical Engineering - From Th
- Page 88 and 89: 76 Biomedical Engineering - From Th
- Page 90 and 91: 78 Biomedical Engineering - From Th
- Page 92 and 93: 80 Biomedical Engineering - From Th
- Page 94 and 95: 82 Biomedical Engineering - From Th
- Page 96 and 97: 84 Biomedical Engineering - From Th
- Page 98 and 99: 86 Biomedical Engineering - From Th
- Page 100 and 101: 88 Biomedical Engineering - From Th
- Page 102 and 103: 90 Biomedical Engineering - From Th
- Page 104 and 105: 92 Biomedical Engineering - From Th
- Page 106 and 107:
94 Biomedical Engineering - From Th
- Page 108 and 109:
96 Biomedical Engineering - From Th
- Page 110 and 111:
98 Biomedical Engineering - From Th
- Page 112 and 113:
100 Biomedical Engineering - From T
- Page 114 and 115:
102 Biomedical Engineering - From T
- Page 116 and 117:
104 Biomedical Engineering - From T
- Page 118 and 119:
106 Biomedical Engineering - From T
- Page 120 and 121:
108 Method (Detection) CIEF-tITP-CZ
- Page 122 and 123:
110 Method (Detection) Analyte Matr
- Page 124 and 125:
112 Biomedical Engineering - From T
- Page 126 and 127:
114 Biomedical Engineering - From T
- Page 128 and 129:
116 Biomedical Engineering - From T
- Page 130 and 131:
118 Biomedical Engineering - From T
- Page 132 and 133:
120 6. Conclusion Biomedical Engine
- Page 134 and 135:
122 Biomedical Engineering - From T
- Page 136 and 137:
124 Biomedical Engineering - From T
- Page 138 and 139:
126 Biomedical Engineering - From T
- Page 140 and 141:
128 Biomedical Engineering - From T
- Page 142 and 143:
130 Biomedical Engineering - From T
- Page 144 and 145:
132 Biomedical Engineering - From T
- Page 146 and 147:
134 Biomedical Engineering - From T
- Page 148 and 149:
136 Biomedical Engineering - From T
- Page 150 and 151:
138 Biomedical Engineering - From T
- Page 152 and 153:
140 Biomedical Engineering - From T
- Page 154 and 155:
142 Biomedical Engineering - From T
- Page 156 and 157:
144 Biomedical Engineering - From T
- Page 158 and 159:
146 Biomedical Engineering - From T
- Page 160 and 161:
148 Biomedical Engineering - From T
- Page 162 and 163:
150 5. Conclusions Biomedical Engin
- Page 164 and 165:
152 Biomedical Engineering - From T
- Page 166 and 167:
154 Biomedical Engineering - From T
- Page 168 and 169:
156 Biomedical Engineering - From T
- Page 170 and 171:
158 Biomedical Engineering - From T
- Page 172 and 173:
160 Biomedical Engineering - From T
- Page 174 and 175:
162 1 st phase : half year 4 2 nd p
- Page 176 and 177:
164 Biomedical Engineering - From T
- Page 178 and 179:
166 7. Innovative active training B
- Page 180 and 181:
168 Biomedical Engineering - From T
- Page 182 and 183:
170 Biomedical Engineering - From T
- Page 184 and 185:
172 12. Maturing projects’ story
- Page 186 and 187:
174 Biomedical Engineering - From T
- Page 188 and 189:
176 Biomedical Engineering - From T
- Page 190 and 191:
178 Biomedical Engineering - From T
- Page 192 and 193:
180 16. Acknowledgments Biomedical
- Page 194 and 195:
182 Biomedical Engineering - From T
- Page 196 and 197:
184 Biomedical Engineering - From T
- Page 198 and 199:
186 Biomedical Engineering - From T
- Page 200 and 201:
188 Biomedical Engineering - From T
- Page 202 and 203:
190 R* M M M M MR*M O O O O M O R*
- Page 204 and 205:
192 Biomedical Engineering - From T
- Page 206 and 207:
194 Biomedical Engineering - From T
- Page 208 and 209:
196 Fig. 9. Chemical structure of 5
- Page 210 and 211:
198 Relative Intensity (AU) Biomedi
- Page 212 and 213:
200 Biomedical Engineering - From T
- Page 214 and 215:
202 Biomedical Engineering - From T
- Page 216 and 217:
204 2. Preparation of IO nanopartic
- Page 218 and 219:
206 Biomedical Engineering - From T
- Page 220 and 221:
208 Biomedical Engineering - From T
- Page 222 and 223:
210 Biomedical Engineering - From T
- Page 224 and 225:
212 Biomedical Engineering - From T
- Page 226 and 227:
214 Biomedical Engineering - From T
- Page 228 and 229:
216 Biomedical Engineering - From T
- Page 230 and 231:
218 Biomedical Engineering - From T
- Page 232 and 233:
220 Biomedical Engineering - From T
- Page 234 and 235:
222 Biomedical Engineering - From T
- Page 236 and 237:
224 Biomedical Engineering - From T
- Page 238 and 239:
226 Biomedical Engineering - From T
- Page 240 and 241:
228 Biomedical Engineering - From T
- Page 242 and 243:
230 Biomedical Engineering - From T
- Page 244 and 245:
232 Biomedical Engineering - From T
- Page 246 and 247:
234 Biomedical Engineering - From T
- Page 248 and 249:
236 Biomedical Engineering - From T
- Page 250 and 251:
238 Biomedical Engineering - From T
- Page 252 and 253:
240 Biomedical Engineering - From T
- Page 254 and 255:
242 Biomedical Engineering - From T
- Page 256 and 257:
244 Biomedical Engineering - From T
- Page 258 and 259:
246 Biomedical Engineering - From T
- Page 260 and 261:
248 Biomedical Engineering - From T
- Page 262 and 263:
250 Biomedical Engineering - From T
- Page 264 and 265:
252 Biomedical Engineering - From T
- Page 266 and 267:
254 Biomedical Engineering - From T
- Page 268 and 269:
256 3. Deposition techniques Biomed
- Page 270 and 271:
258 Biomedical Engineering - From T
- Page 272 and 273:
260 Biomedical Engineering - From T
- Page 274 and 275:
262 Biomedical Engineering - From T
- Page 276 and 277:
264 Biomedical Engineering - From T
- Page 278 and 279:
266 Biomedical Engineering - From T
- Page 280 and 281:
268 Biomedical Engineering - From T
- Page 282 and 283:
270 Biomedical Engineering - From T
- Page 284 and 285:
272 Biomedical Engineering - From T
- Page 286 and 287:
274 Biomedical Engineering - From T
- Page 288 and 289:
276 Biomedical Engineering - From T
- Page 290 and 291:
278 Biomedical Engineering - From T
- Page 292 and 293:
280 Biomedical Engineering - From T
- Page 294 and 295:
282 Biomedical Engineering - From T
- Page 296 and 297:
284 Biomedical Engineering - From T
- Page 298 and 299:
286 Biomedical Engineering - From T
- Page 300 and 301:
288 Biomedical Engineering - From T
- Page 302 and 303:
290 Biomedical Engineering - From T
- Page 304 and 305:
292 Biomedical Engineering - From T
- Page 306 and 307:
294 Biomedical Engineering - From T
- Page 308 and 309:
296 Biomedical Engineering - From T
- Page 310 and 311:
298 Biomedical Engineering - From T
- Page 312 and 313:
300 2. Nanoparticles in biomedical
- Page 314 and 315:
302 Biomedical Engineering - From T
- Page 316 and 317:
304 Biomedical Engineering - From T
- Page 318 and 319:
306 Biomedical Engineering - From T
- Page 320 and 321:
308 Biomedical Engineering - From T
- Page 322 and 323:
310 Biomedical Engineering - From T
- Page 324 and 325:
312 Biomedical Engineering - From T
- Page 326 and 327:
314 Biomedical Engineering - From T
- Page 328 and 329:
316 Biomedical Engineering - From T
- Page 330 and 331:
318 Biomedical Engineering - From T
- Page 332 and 333:
320 Biomedical Engineering - From T
- Page 334 and 335:
322 Biomedical Engineering - From T
- Page 336 and 337:
324 Biomedical Engineering - From T
- Page 338 and 339:
326 Biomedical Engineering - From T
- Page 340 and 341:
328 Biomedical Engineering - From T
- Page 342 and 343:
330 Biomedical Engineering - From T
- Page 344 and 345:
332 Biomedical Engineering - From T
- Page 346 and 347:
334 Biomedical Engineering - From T
- Page 348 and 349:
336 Biomedical Engineering - From T
- Page 350 and 351:
338 Biomedical Engineering - From T
- Page 352 and 353:
340 Biomedical Engineering - From T
- Page 354 and 355:
342 Biomedical Engineering - From T
- Page 356 and 357:
344 Biomedical Engineering - From T
- Page 358 and 359:
346 Biomedical Engineering - From T
- Page 360 and 361:
348 Biomedical Engineering - From T
- Page 362 and 363:
350 Biomedical Engineering - From T
- Page 364 and 365:
352 Biomedical Engineering - From T
- Page 366 and 367:
354 Biomedical Engineering - From T
- Page 368 and 369:
356 Biomedical Engineering - From T
- Page 370 and 371:
358 Biomedical Engineering - From T
- Page 372 and 373:
360 Biomedical Engineering - From T
- Page 374 and 375:
362 Biomedical Engineering - From T
- Page 376 and 377:
364 Biomedical Engineering - From T
- Page 378 and 379:
366 Biomedical Engineering - From T
- Page 380 and 381:
368 Biomedical Engineering - From T
- Page 382 and 383:
370 Biomedical Engineering - From T
- Page 384 and 385:
372 Biomedical Engineering - From T
- Page 386 and 387:
374 Biomedical Engineering - From T
- Page 388 and 389:
376 Biomedical Engineering - From T
- Page 390 and 391:
378 Biomedical Engineering - From T
- Page 392 and 393:
380 Biomedical Engineering - From T
- Page 394 and 395:
382 Biomedical Engineering - From T
- Page 396 and 397:
384 Biomedical Engineering - From T
- Page 398 and 399:
386 Biomedical Engineering - From T
- Page 400 and 401:
388 Biomedical Engineering - From T
- Page 402 and 403:
390 Biomedical Engineering - From T
- Page 404 and 405:
392 Biomedical Engineering - From T
- Page 406 and 407:
394 Biomedical Engineering - From T
- Page 408 and 409:
396 Biomedical Engineering - From T
- Page 410 and 411:
398 Biomedical Engineering - From T
- Page 412 and 413:
400 Biomedical Engineering - From T
- Page 414 and 415:
402 Biomedical Engineering - From T
- Page 416 and 417:
404 Biomedical Engineering - From T
- Page 418 and 419:
406 Biomedical Engineering - From T
- Page 420 and 421:
408 Biomedical Engineering - From T
- Page 422 and 423:
410 Biomedical Engineering - From T
- Page 424 and 425:
412 Biomedical Engineering - From T
- Page 426 and 427:
414 Biomedical Engineering - From T
- Page 428 and 429:
416 Biomedical Engineering - From T
- Page 430 and 431:
418 Biomedical Engineering - From T
- Page 432 and 433:
420 Biomedical Engineering - From T
- Page 434 and 435:
422 Biomedical Engineering - From T
- Page 436 and 437:
424 Biomedical Engineering - From T
- Page 438 and 439:
426 Biomedical Engineering - From T
- Page 440 and 441:
428 Biomedical Engineering - From T
- Page 442 and 443:
430 Biomedical Engineering - From T
- Page 444 and 445:
432 Biomedical Engineering - From T
- Page 446 and 447:
434 3. Three dimensional virtual mo
- Page 448 and 449:
436 Biomedical Engineering - From T
- Page 450 and 451:
438 Biomedical Engineering - From T
- Page 452 and 453:
440 Biomedical Engineering - From T
- Page 454 and 455:
442 Biomedical Engineering - From T
- Page 456 and 457:
444 Biomedical Engineering - From T
- Page 458 and 459:
446 Biomedical Engineering - From T
- Page 460 and 461:
448 Biomedical Engineering - From T
- Page 462 and 463:
450 Biomedical Engineering - From T
- Page 464 and 465:
452 Biomedical Engineering - From T
- Page 466 and 467:
454 In this case, the eigenvalues a
- Page 468 and 469:
456 where Biomedical Engineering -
- Page 470 and 471:
458 Biomedical Engineering - From T
- Page 472 and 473:
460 Biomedical Engineering - From T
- Page 474 and 475:
462 Biomedical Engineering - From T
- Page 476 and 477:
464 Biomedical Engineering - From T
- Page 478 and 479:
466 Biomedical Engineering - From T
- Page 480 and 481:
468 Biomedical Engineering - From T
- Page 482 and 483:
470 Biomedical Engineering - From T
- Page 484 and 485:
472 Nb b b l l1 Biomedical Engineer
- Page 486 and 487:
474 Biomedical Engineering - From T
- Page 488 and 489:
476 Biomedical Engineering - From T
- Page 490 and 491:
478 Load F (μN) Parallel-oriented
- Page 492 and 493:
480 Biomedical Engineering - From T
- Page 494 and 495:
482 Biomedical Engineering - From T
- Page 496 and 497:
484 Biomedical Engineering - From T
- Page 498:
486 Biomedical Engineering - From T